It has been shown that the IL-4/STAT6 and IL-13/STAT6 signaling pathways exacerbate the progression of metabolically induced liver fibrosis in mice on HFD (Hart et al., 2017). This evidence concerns the gene IL13 and Hepatic fibrosis.